Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jun-Jul;45(5):289-297.
doi: 10.1016/j.medine.2019.10.008. Epub 2020 Apr 21.

Impact of a modification of the clinical practice guide of the American Academy of Pediatrics in the management of severe acute bronchiolitis in a pediatric intensive care unit

Affiliations
Observational Study

Impact of a modification of the clinical practice guide of the American Academy of Pediatrics in the management of severe acute bronchiolitis in a pediatric intensive care unit

C Guitart et al. Med Intensiva (Engl Ed). 2021 Jun-Jul.

Abstract

Objective: To describe the characteristics and evolution of patients with bronchiolitis admitted to a pediatric intensive care unit, and compare treatment pre- and post-publication of the American Academy of Pediatrics clinical practice guide.

Design: A descriptive and observational study was carried out between September 2010 and September 2017.

Setting: Pediatric intensive care unit.

Patients: Infants under one year of age with severe bronchiolitis.

Interventions: Two periods were compared (2010-14 and 2015-17), corresponding to before and after modification of the American Academy of Pediatrics guidelines for the management of bronchiolitis in hospital.

Main variables: Patient sex, age, comorbidities, severity, etiology, administered treatment, bacterial infections, respiratory and inotropic support, length of stay and mortality.

Results: A total of 706 patients were enrolled, of which 414 (58.6%) males, with a median age of 47 days (IQR 25-100.25). Median bronchiolitis severity score (BROSJOD) upon admission: 9 points (IQR 7-11). Respiratory syncytial virus appeared in 460 (65.16%) patients. The first period (2010-14) included 340 patients and the second period (2015-17) 366 patients. More adrenalin and hypertonic saline nebulizations and more corticosteroid treatment were administered in the second period. More noninvasive ventilation and less conventional mechanical ventilation were used, and less inotropic support was needed, with no significant differences. The antibiotherapy rate decreased significantly (p=0.003).

Conclusions: Despite the decrease in antibiotherapy, the use of nebulizations and glucocorticoids in these patients should be limited, as recommended by the guide.

Objetivo: Describir las características y la evolución de los pacientes con bronquiolitis ingresados en una unidad de cuidados intensivos pediátricos. Comparar el tratamiento administrado pre y pospublicación de la guía de práctica clínica de la Academia Americana de Pediatría.

Diseño: Estudio descriptivo y observacional realizado entre septiembre de 2010 y septiembre de 2017.

Configuración: Unidad de cuidados intensivos pediátricos.

Pacientes: Menores de un año con bronquiolitis grave.

Intervenciones: Se compararon 2 períodos (2010-14 y 2015-17), antes y después de la modificación del protocolo de manejo de la bronquiolitis en el hospital, según las guías de la Academia Americana de Pediatría.

Principales variables: Sexo, edad, comorbilidades, gravedad, etiología, tratamiento administrado, infecciones bacterianas, soporte respiratorio e inotrópico, estancia y mortalidad.

Resultados: Se recogieron 706 pacientes, 414 (58,6%) varones, con una mediana de edad de 47 días (RIC 25-100,25). Mediana de escala de gravedad de bronquiolitis (BROSJOD) al ingreso: 9 puntos (RIC 7-11). La etiología por virus respiratorio sincitial se dio en 460 (65,16%) pacientes. El primer período (2010-14) incluyó 340 pacientes y el segundo (2015-17), 366 pacientes. En el segundo período se administraron más nebulizaciones de adrenalina y suero salino hipertónico, y más tratamiento con corticoides. Se usó más ventilación no invasiva y menos ventilación mecánica convencional y precisaron menos soporte inotrópico, sin diferencias significativas. La tasa de antibioterapia disminuyó de forma estadísticamente significativa (p = 0,003).

Conclusiones: Pese a la disminución en la antibioterapia, se debería limitar la utilización de nebulizaciones y corticoides en estos pacientes, como recomienda la guía.

Keywords: Acute respiratory failure; Bronchiolitis; Bronquiolitis; Cuidados intensivos; Insuficiencia respiratoria aguda; Intensive care; Pediatrics; Pediatría.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Management algorithm corresponding to acute bronchiolitis in our hospital following publication of the Clinical Practice Guide (CPG) of the American Association of Pediatrics (AAP). ABCDE: sequential evaluation; BROSJOD: Bronchiolitis Score of Sant Joan de Deu (bronchiolitis clinical severity scale); CPAP: continuous positive airway pressure; FiO2: fraction of inspired oxygen; HFO: high-flow oxygen therapy; PCO2: blood carbon dioxide partial pressure; Sat: hemoglobin saturation; 3% HSS: 3% hypertonic saline solution; PET: pediatric evaluation triangle.

Similar articles

Cited by

References

    1. Meissner H.C. Viral bronchiolitis in children. N Engl J Med. 2016;374:62–72. - PubMed
    1. Chkhaidze I., Zirakashvili D. Acute viral bronchiolitis in infants. Georgian Med News. 2017;264:43–50. - PubMed
    1. Smith D.K., Seales S., Budzik C. Respiratory syncytial virus bronchiolitis in children. Am Fam Physician. 2017;95:94–99. - PubMed
    1. Fretzayas A., Moustaki M. Etiology and clinical features of viral bronchiolitis in infancy. World J Pediatr. 2017;13:293–299. - PMC - PubMed
    1. Mansbach J.M., Piedra P.A., Teach S.J., Sullivan A.F., Forgey T., Clark S., et al. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med. 2012;166:700–706. - PMC - PubMed

Publication types